416
Views
70
CrossRef citations to date
0
Altmetric
Research Article

Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators

&
Pages 57-70 | Received 04 Nov 2010, Accepted 11 Apr 2011, Published online: 07 Dec 2011

References

  • Albini, A, Iwamoto, Y, Kleinman, HK, Martin, GR, Aaronson, SA, Kozlowski, JM, et al. (1987). A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239–3245.
  • Bergers, G., Brekken, R., Mcmahon, G., Vu, T. H., Itoh, T., Tamaki, K., et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744.
  • Bharti, A. C., Aggarwal, B. B. (2002). Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 64:883–888.
  • Bhat, T. A., Singh, R. P. (2008). Tumor angiogenesis—a potential target in cancer chemoprevention. Food Chem Toxicol 46;1334–1345.
  • Boosani, C. S., Mannam, A. P., Cosgrove, D., Silva, R., Hodivala-Dilke, K. M., Keshamouni, V. G., et al (2007). Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis. Blood 110:1168–1177.
  • Brown, J. M., Giaccia, A. J. (1998). The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408–1416.
  • Campling, B. G., Pym, J., Baker, H. M., Cole, S. P., Lam, Y. M. (1991). Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 63:75–83.
  • Carmeliet, P. (2005). VEGF as a key mediator of angiogenesis in cancer. Oncology 69:4–10.
  • Cianchi, F., Cuzzocrea, S., Vinci, M. C., Messerini, L., Comin, C. E., Navarra, G., et al. (2010). Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis. Dig Liver Dis 42:20–27.
  • Cole, S. P. (1986). Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 17:259–263.
  • Cox, G., Steward, W. P., O’Byrne, K. J. (1999). The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax 54:169–179.
  • Dignam, J. D., Lebovitz, R. M., Roeder, R. G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489.
  • Dong, X., Han, Z. C., Yang, R. (2007). Angiogenesis and antiangiogenic therapy in hematologic malignancies. Crit Rev Oncol Hematol 62:105–118.
  • Duffy, M. J., Mcgowan, P. M., Gallagher, W. M. (2008). Cancer invasion and metastasis: changing views. J Pathol 214:283–293.
  • Dvorak, H. F. (2005). Angiogenesis: update 2005. J Thromb Haemost 3:1835–1842.
  • Eun, J. P., Koh, G. Y. (2004). Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem Biophys Res Commun 317:618–624.
  • Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., Fujiwara, H. (1999a). Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66:227–233.
  • Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., Fujiwara, H. (1999b). Inhibition of activator protein-1 by berberine in human hepatoma cells. Planta Med 65:381–383.
  • Fukumura, D., Jain, R. K. (1998). Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metast Rev 17:77–89.
  • Gao, J. L., Shi, J. M., Lee, S. M., Zhang, Q. W., Wang, Y. T. (2009). Angiogenic pathway inhibition of Corydalis yanhusuo and berberine in human umbilical vein endothelial cells. Oncol Res 17:519–526.
  • Goodwin, A. M. (2007). In vitro assays of angiogenesis for assessment of angiogenic and antiangiogenic agents. Microvasc Res 74:172–183.
  • Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., Tannenbaum, S. R. (1982). Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138.
  • Guo, H. B., Lee, I., Kamar, M., Akiyama, S. K., Pierce, M. (2002). Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res 62:6837–6845.
  • Gupta, K., Kshirsagar, S., Chang, L., Schwartz, R., Law, P. Y., Yee, D., et al. (2002). Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491–4498.
  • Hanahan, D., Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364.
  • Harris, A. L. (2002). Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47.
  • Hirota, K., Semenza, G. L. (2006). Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 59:15–26.
  • Ho, Y. T., Yang, J. S., Li, T. C., Lin, J. J., Lin, J. G., Lai, K. C., et al. (2009). Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA, and MMP-2 and -9. Cancer Lett 279:155–162.
  • Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., Fidler, I. J. (2001). Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20:4188–4197.
  • Huang, S. T., Yang, R. C., Lee, P. N., Yang, S. H., Liao, S. K., Chen, T. Y., et al. (2006). Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma. Int Immunopharmacol 6:870–879.
  • Jaffe, E. A., Nachman, R. L., Becker, C. G., Minick, C. R. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745–2756.
  • Karin, M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441, 431–436.
  • Kishi, K., Petersen, S., Petersen, C., Hunter, N., Mason, K., Masferrer, J. L., et al. (2000). Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 60:1326–1331.
  • Kruczynski, A., Poli, M., Dossi, R., Chazottes, E., Berrichon, G., Ricome, C., et al. (2006). Anti-angiogenic, vascular-disrupting, and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development. Eur J Cancer 42:2821–2832.
  • Kumazaki, K., Nakayama, M., Suehara, N., Wada, Y. (2002). Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol 33:1069–1077.
  • Lin, S., Tsai, S. C., Lee, C. C., Wang, B. W., Liou, J. Y., Shyu, K. G. (2004). Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 66:612–619.
  • Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., Shafie, S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68.
  • Macdougall, J. R., Matrisian, L. M. (1995). Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion, and metastasis. Cancer Metast Rev 14:351–362.
  • Makrilia, N., Lappa, T., Xyla, V., Nikolaidis, I, Syrigos, K. (2009). The role of angiogenesis in solid tumours: an overview. Eur J Intern Med 20;663–671.
  • Masson, V. V., Devy, L., Grignet-Debrus, C., Bernt, S., Bajou, K., Blacher, S., et al. (2002). Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis. Biol Proced Online 4:24–31.
  • Mayorga, M., Iborra, A., Estany, S., Martinez, P. (2004). Protective effect of vitamin E in an animal model of LPS-induced inflammation. Am J Reprod Immunol 52:356–361.
  • Ninck, S., Reisser, C., Dyckhoff, G., Helmke, B., Bauer, H., Herold-Mende, C. (2003). Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 106:34–44.
  • Nyberg, P., Xie, L., Kalluri, R. (2005). Endogenous inhibitors of angiogenesis. Cancer Res 65:3967–3979.
  • Overall, C. M., Lopez-Otin, C. (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657–672.
  • Ramjaun, A. R., Hodivala-Dilke, K. (2009). The role of cell adhesion pathways in angiogenesis. Int J Biochem Cell Biol 41:521–530.
  • Rappolee, D. A., Werb, Z. (1992). Macrophage-derived growth factors. Curr Top Microbiol Immunol 181:87–140.
  • Ribatti, D., Guidolin, D., Conconi, M. T., Nico, B., Baiguera, S., Parnigotto, P. P., et al. (2003). Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene, 22, 6458–61.
  • Risau, W., Flamme, I. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11:73–91.
  • Roberts, W. G., Palade, G. E. (1997). Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 57:765–772.
  • Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., Kuttan, R. (1995). Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79–83.
  • Sappayatosok, K., Maneerat, Y., Swasdison, S., Viriyavejakul, P., Dhanuthai, K., Zwang, J., et al. (2009). Expression of pro-inflammatory protein, iNOS, VEGF, and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis, and their clinico-pathological correlation. Med Oral Patol Oral Cir Bucal 14:E319–E324.
  • Sathyavathi, G. V., Gupta, A. K., Tandon, N. (1987). Medicinal plants of India (pp. 230–239). Indian Council of Medical Research, New Delhi, India.
  • Tolsma, S. S., Stack, M. S., Bouck, N. (1997). Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1. Microvasc Res 54:13–26.
  • Tsujii, M., Kawano, S., Dubois, R. N. (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 94:3336–3340.
  • Wu, Y., Zhou, B. P. (2009). Inflammation: a driving force speeds cancer metastasis. Cell Cycle 8:3267–3273.
  • Zhang, J., Peng, B. (2009). NF-κ B promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro. Cell Prolif 42:150–161.
  • Zhu, W. H., Nicosia, R. F. (2002). The thin prep rat aortic ring assay: a modified method for the characterization of angiogenesis in whole mounts. Angiogenesis 5:81–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.